- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07693465
Impact of Spinal Alignment on Pelvic Floor Efficiency
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Pelvic floor dysfunction (PFD) may extend beyond the pelvic region by inducing myofascial disturbances in anatomically distant structures connected through the myofascial network. Among these, low back pain (LBP) is one of the most frequently reported musculoskeletal conditions associated with PFD. This relationship is thought to arise from lumbopelvic instability and altered coordination of the core musculature. The pelvic floor muscles (PFMs), together with the transversus abdominis, diaphragm, and multifidus, form an integrated stabilizing system that contributes to spinal stability and postural control. Consequently, dysfunction of the transversus abdominis may compromise not only pelvic floor function but also overall lumbopelvic stability. Women with LBP have been shown to exhibit reduced PFM contraction strength despite preserved transversus abdominis activation, suggesting that impaired PFM function may play a more prominent role in the development of LBP than deficits in the abdominal muscles alone. Conversely, inadequate activation or endurance of the transversus abdominis has also been associated with impaired PFM function. Furthermore, altered movement patterns, dysfunctional breathing, and postural deviations can disrupt load transfer through the lumbopelvic region, thereby increasing the risk of PFD.
There is a dearth of knowledge regarding the effect of spinal alignment on pelvic floor efficiency in nulliparous women. This study, therefore, contributes valuable insights into a relatively unexplored area of nulliparous women's health. By assessing the pelvic floor muscles in nulliparous women with different spinal alignment patterns, including lordosis, kyphosis, and scoliosis, this study may enhance the well-being of nulliparous women, provide a more comprehensive approach to health improvement, help protect them from future pelvic floor dysfunction, and broaden the scope of physiotherapy in women's health.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Giza, Egypte
- Faculty of Physical Therapy, Cairo University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Nulliparous women.
- Their ages will range from 25 to 35 years old.
- Their body mass index (BMI) will not exceed 29.9 Kg/m2.
Exclusion Criteria:
- Female with congenital spinal deformity.
- Female with a history of neuromuscular disease.
- Female Diagnosed with any systemic disease .
- Female with a history of malignancy and/or ongoing treatment.
- Female with a history of urogenital diseases and surgical history.
- Female with previous spinal surgery.
- Female with previous pregnancy .
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Nulliparous women with thoracolumbar scoliosis
Twenty nulliparous women with thoracolumbar scoliosis.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Geen tussenkomst
|
|
Nulliparous women with hyperlordosis
Twenty nulliparous women with hyperlordosis.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Geen tussenkomst
|
|
Nulliparous women with thoracic kyphosis
Twenty nulliparous women with thoracic kyphosis.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Geen tussenkomst
|
|
Nulliparous women with normal spinal alignment
Twenty nulliparous women with normal spinal alignment.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Geen tussenkomst
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Pelvic floor muscle strength
Tijdsspanne: Baseline
|
Pelvic floor muscle strength was measured using vaginal pressure biofeedback (maximum voluntary contraction pressure).
|
Baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Pelvic floor muscle endurance
Tijdsspanne: Baseline
|
Pelvic floor muscle endurance was assessed using vaginal pressure biofeedback (duration of sustained maximal voluntary contraction).
|
Baseline
|
|
Spinal alignment angle
Tijdsspanne: Baseline
|
It was measured using the DIERS Formetric 4D system.
|
Baseline
|
|
Pelvic floor dysfunction symptoms
Tijdsspanne: Baseline
|
Total score and domain scores (bladder, bowel, prolapse, and sexual function) were assessed using the Australian Pelvic Floor Questionnaire (APFQ).
|
Baseline
|
|
Health-related quality of life
Tijdsspanne: Baseline
|
It was assessed by using Free online SF-12 Health Survey Version 2 (SF-12v2) score calculator.
The SF-12V2 measures eight scales: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
|
Baseline
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Afaf Mohamed Mahmoud Botla, PhD, Professor, Cairo University
- Studie directeur: Amira Nagy Abd Ellatief Hamad, PhD, Lecturer, Cairo University
- Studie directeur: Amal Abd Elrahman Mohamed Elborady, Assist. Professor, Cairo University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- P.T.REC/012/005314
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .